Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Sales 2020 | 304M 325M | Sales 2021 | 328M 351M | Capitalization | 724M 774M |
---|---|---|---|---|---|
Net income 2020 | 33M 35.29M | Net income 2021 | 60M 64.17M | EV / Sales 2020 | 3.16 x |
Net Debt 2020 | 237M 254M | Net Debt 2021 | 249M 266M | EV / Sales 2021 | 2.97 x |
P/E ratio 2020 |
21.5
x | P/E ratio 2021 |
11.9
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 18-12-31 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-10 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 15-11-09 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+5.73% | 71.48B | |
+11.94% | 9.18B | |
-15.34% | 4.79B | |
+34.54% | 3.98B | |
+5.09% | 3.97B | |
+27.76% | 2.56B | |
-28.33% | 2.29B | |
-24.15% | 2.23B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- STAGR Stock